New Local Clinical Trial Recruiting Now!

Written by Victoria Rogan

In exciting news for both the Australian & New Zealand FA communities, Design Therapeutics are enroling for local clinical trials for their DT-216P2 medication. This important study is currently taking place in Melbourne & Sydney.

Please read the Design Therapeutics communication below regarding the trial and enrolment.

Victoria Rogan
Previous

TGA list SKYCLARYS on the Australian Register of Therapeutic Goods  
Next

omav Early Access Program Not Impacted by PBAC Decision